287 related articles for article (PubMed ID: 31514057)
1. Generation of six induced pluripotent stem cell (iPSC) lines from two patients with amyotrophic lateral sclerosis (NUIGi043-A, NUIGi043-B, NUIGi043-C, NUIGi044-A, NUIGi044-B, NUIGi044-C).
Yang M; Liu M; Vajda A; O'Brien T; Henshall D; Hardiman O; Shen S
Stem Cell Res; 2019 Oct; 40():101558. PubMed ID: 31514057
[TBL] [Abstract][Full Text] [Related]
2. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
[TBL] [Abstract][Full Text] [Related]
3. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
4. Generation of three induced pluripotent stem cell lines from an isolated inherited retinal dystrophy patient with RCBTB1 frameshifting mutations.
Huang Z; Zhang D; Chen SC; Thompson JA; McLaren T; Lamey T; De Roach JN; McLenachan S; Chen FK
Stem Cell Res; 2019 Oct; 40():101549. PubMed ID: 31494449
[TBL] [Abstract][Full Text] [Related]
5. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
[TBL] [Abstract][Full Text] [Related]
6. Generation of patient-specific pluripotent induced stem cell line UFRJi007-A from a Brazilian familial amyotrophic lateral sclerosis patient.
Gubert F; Vasques JF; Cozendey TD; Domizi P; Toledo MF; Kasai-Brunswick TH; Hochman-Mendez C; Junior MC; Zembrzuski VM; Loureiro MPS; Lima JMB; Gress CH; Cabello GMK; Cabello PH; Borgonovo T; Vaz IM; Silva R; Mendez-Otero R
Stem Cell Res; 2019 Aug; 39():101490. PubMed ID: 31301488
[TBL] [Abstract][Full Text] [Related]
7. Generation of seven iPSC lines from peripheral blood mononuclear cells suitable to investigate Autism Spectrum Disorder.
Bozaoglu K; Gao Y; Stanley E; Fanjul-Fernández M; Brown NJ; Pope K; Green CC; Vlahos K; Sourris K; Bahlo M; Delatycki M; Scheffer I; Lockhart PJ
Stem Cell Res; 2019 Aug; 39():101516. PubMed ID: 31415975
[TBL] [Abstract][Full Text] [Related]
8. Generation of two human iPSC lines (MDCUi001-A and MDCUi001-B) from dermal fibroblasts of a Thai patient with X-linked osteogenesis imperfecta using integration-free Sendai virus.
Tongkobpetch S; Rungsiwiwut R; Pruksananonda K; Suphapeetiporn K; Shotelersuk V
Stem Cell Res; 2019 Aug; 39():101493. PubMed ID: 31326747
[TBL] [Abstract][Full Text] [Related]
9. Integration-free induced pluripotent stem cells derived from a patient with autosomal recessive Alport syndrome (ARAS).
Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
Stem Cell Res; 2017 Dec; 25():1-5. PubMed ID: 29246570
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of a human iPSC line (UAMi005-A) from a patient with nonketotic hyperglycinemia due to mutations in the GLDC gene.
Arribas-Carreira L; Bravo-Alonso I; López-Márquez A; Alonso-Barroso E; Briso-Montiano Á; Arroyo I; Ugarte M; Pérez B; Pérez-Cerdá C; Rodríguez-Pombo P; Richard E
Stem Cell Res; 2019 Aug; 39():101503. PubMed ID: 31349202
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
[TBL] [Abstract][Full Text] [Related]
12. Generation of human iPS cell line IBCHi001-A from dentatorubral-pallidoluysian atrophy patient's fibroblasts.
Kozlowska E; Ciolak A; Olejniczak M; Fiszer A
Stem Cell Res; 2019 Aug; 39():101512. PubMed ID: 31374462
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo differentiation of induced pluripotent stem cells into male germ cells.
Cai H; Xia X; Wang L; Liu Y; He Z; Guo Q; Xu C
Biochem Biophys Res Commun; 2013 Apr; 433(3):286-91. PubMed ID: 23524261
[TBL] [Abstract][Full Text] [Related]
14. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL
Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167
[TBL] [Abstract][Full Text] [Related]
15. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
[TBL] [Abstract][Full Text] [Related]
16. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
17. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
Okada M; Yoneda Y
Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
[TBL] [Abstract][Full Text] [Related]
18. Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation.
Russ K; Marote A; Savchenko E; Collin A; Goldwurm S; Pomeshchik Y; Roybon L
Stem Cell Res; 2018 Mar; 27():61-64. PubMed ID: 29331938
[TBL] [Abstract][Full Text] [Related]
19. Development of one control and one tumor-specific induced pluripotent stem cell line from laryngeal carcinoma patient.
Zhang Y; Zhu J; Dai Y; Wang L; Liu R
Stem Cell Res; 2017 Dec; 25():283-285. PubMed ID: 29246575
[TBL] [Abstract][Full Text] [Related]
20. Generation of three human induced pluripotent stem cell sublines (MZT04D, MZT04J, MZT04C) for reproductive science research.
Pandolfi EC; Rojas EJ; Sosa E; Gell JJ; Hunt TJ; Goldsmith S; Fan Y; Silber SJ; Clark AT
Stem Cell Res; 2019 Oct; 40():101576. PubMed ID: 31622877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
